Ajanta Pharma
Ajanta Pharma Limited, headquartered in India, is a prominent player in the pharmaceutical industry, specialising in the development and manufacturing of a diverse range of formulations. Founded in 1973, the company has established a strong presence in various operational regions, including Asia, Africa, and the Middle East. Ajanta Pharma is renowned for its focus on therapeutic areas such as ophthalmology, dermatology, and pain management, offering unique products that cater to specific medical needs. With a commitment to quality and innovation, the company has achieved significant milestones, including numerous approvals from regulatory authorities worldwide. Recognised for its robust market position, Ajanta Pharma continues to expand its global footprint, driven by a dedication to enhancing patient care through effective and affordable healthcare solutions.
DitchCarbon Score
How does Ajanta Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ajanta Pharma's score of 19 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ajanta Pharma's reported carbon emissions
In 2023, Ajanta Pharma reported total carbon emissions of approximately 56,143,900 kg CO2e, comprising about 4,368,550 kg CO2e from Scope 1 and about 51,847,350 kg CO2e from Scope 2. This represents a slight increase in emissions compared to 2022, where total emissions were about 51,944,670 kg CO2e, with Scope 1 emissions at approximately 4,611,220 kg CO2e and Scope 2 emissions at about 46,633,150 kg CO2e. The company has not disclosed any specific reduction targets or initiatives as part of its climate commitments. However, it continues to monitor and report its emissions, indicating a level of transparency in its environmental impact. The emissions intensity per rupee of turnover has shown fluctuations, with a reported intensity of approximately 0.123 kg CO2e per rupee in 2023, compared to 0.116 kg CO2e in 2022. Ajanta Pharma's commitment to addressing climate change is evident through its ongoing emissions reporting, although specific reduction strategies or targets have not been outlined. The pharmaceutical industry is increasingly focusing on sustainability, and Ajanta Pharma's emissions data reflects its participation in this broader trend.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 3,660,360 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 41,756,300 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ajanta Pharma is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
